Author

T. Okamoto

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real‐World Study

To describe post‐recurrence treatment patterns and outcomes after adjuvant nivolumab for urothelial carcinoma in real‐world practice.

Izuki Ogawa, T. Narita, Masanao Shinohara et al. · International journal of uro... · 0 citations

Review Aug 2026

A phase-specific benefit-toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis.

The perioperative treatment landscape for muscle-invasive bladder cancer is changing rapidly with the emergence of immune checkpoint inhibitor- and antibody-drug conjugate-based strategies. Trials such as NIAGARA, EV-304/KEYNOTE-B15, and EV-303/KEYNOTE-905 have shown substantial improvements in event-free survival, ove...

Masanao Shinohara, T. Narita, T. Hamaya et al. · Urologic oncology · 1 citation